Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Prior to Radical Prostatectomy in High-Risk Localized Prostate Cancer
NCT00466752Phase 2Completed
- Sponsor
- University of Washington
- Start
- Dec 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in prostate cancer (PCa), sponsored by University of Washington. Started Dec 2006; status: completed.
02
Drugs
sorafenib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00466752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466752.